Proactive - Interviews for investors

Dropsuite Ltd (ASX:DSE) CFO Bill Kyriacou sits down with Proactive's Tylah Tully live from the ASX Small and Mid Cap Conference in September 2024.

The company simplifies data protection, including backup of Microsoft 365, Microsoft 365 GovCloud, Google Workspace, QuickBooks Online and websites.

Dropsuite helps businesses adhere to compliance regulations with email archiving, eDiscovery and GDPR Responder.

#ProactiveInvestors #Dropsuite #ASX

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Microba Life Sciences Ltd (ASX:MAP) CEO Dr Luke Reid sits down with Proactive's Tylah Tully live from the ASX Small and Mid Cap Conference in September 2024.

Microba Life Sciences believes in comprehensive and precise measurement of the human gut microbiome to drive innovation in medical care.

Through its analysis and discovery platforms, the company identifies novel microbiome-derived therapeutics and new diagnostic tools to advance medicine.

The growing team is built on a foundation of scientific and technical excellence and a drive to discover ever-deeper insights into the relationships between gut microorganisms and health.

The company works with international partners who share its passion and scientific rigour to fast-track these new advances.

#ProactiveInvestors #MicrobaLifeSciences #ASX

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

ECS Botanics Holdings Ltd (ASX:ECS) managing director Nan-Maree Schoerie sits down with Proactive's Tylah Tully live from the ASX Small and Mid Cap Conference in September 2024.

ECS is an Australian medicinal cannabis cultivator and manufacturer, with facilities in Victoria that uses progressive and innovative cultivation methodologies to reduce costs in an environmentally friendly way, adopting regenerative and organic agricultural practices, renewable energies, and striving for zero waste.

With PIC/S GMP (EU-GMP equivalent) certification, and by focusing on reducing costs, ECS Botanics has become a leading Australian Cannabis Cultivator provider of high quality, affordable, medicinal cannabis to businesses.

#ProactiveInvestors #ECSBotanics #ASX #Cannabis #MedicinalMarijuana

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Acrux Ltd (ASX:ACR) CEO and managing director Michael Kotsanis chats with Proactive's Tylah Tully live from the ASX Small and Mid Cap Conference in September 2024.

Acrux is a specialty pharma company with a track record of developing and commercialising a pipeline of topically applied pharmaceutical products.

Drawing on 25 years of experience, Acrux has marketed through licensees several products worldwide with emphasis on the US.

Acrux is formulating and developing a range of topical generic products by leveraging its highly skilled workforce, on-site laboratories, GMP manufacturing suite, technical, clinical and commercial experience to bring affordable products to market.

The company encourages collaboration and is well positioned to discuss commercial partnering and product development opportunities.

#ProactiveInvestors #Acrux #ASX

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

BCAL Diagnostics Ltd (ASX:BDX) executive chair Jayne Shaw sits down with Proactive's Tylah Tully live from the ASX Small and Mid Cap Conference in September 2024.

BCAL is dedicated to achieving early and accurate diagnoses of breast cancer, with a primary focus on facilitating early intervention, ultimately leading to improved outcomes for women.

For more than a decade, BCAL has been developing non-invasive technologies to assist clinicians in the detection of breast cancer.

The cutting-edge technology was initially designed to complement existing imaging technologies such as the mammogram, but is now primed to evolve into a comprehensive monitoring and screening tool accessible to women of all ages and backgrounds, regardless of location.

#ProactiveInvestors #BCALDiagnostics #ASX #Oncology #BreastCancer

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Aroa Biosurgery Ltd (ASX:ARX) CFO James Agnew sits down with Proactive's Tylah Tully live from the ASX Small and Mid Cap Conference in September 2024.

Aroa describes itself as a soft-tissue regeneration company that develops, manufactures and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction.

The company, which was formerly called Mesynthes, initially contracted scientists from Industrial Research Ltd to get started and then rapidly transitioned to its own internal development team to accelerate commercialisation.

Early in 2014, Aroa Biosurgery relocated and expanded into a new purpose-built facility in Auckland, New Zealand.

Nowadays, Agnew says Aroa is committed to ‘unlocking regenerative healing for everybody’ and that more than 6.5 million AROA products have been used globally in a range of procedures to date.

#ProactiveInvestors #AroaBiosurgery #ASX #SoftTissueRegeneration #RegenerativeHealing

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Botanix Ltd (ASX:BOT) CEO Dr Howie McKibbon sits down with Proactive's Tylah Tully live from the ASX Small and Mid Cap Conference in September 2024.

Chaired by Phoenix-based pharmaceutical magnate Vince Ippolito, the company is on a mission to create innovative solutions for common (yet overlooked) skin diseases and infections.

Amid growing demand for these kinds of treatments, Botanix has assembled a team of dermatology, clinical research and commercialisation experts to further its portfolio.

According to Dr McKibbon, the company wants to use its clinical expertise to deliver first-in-class treatments at the highest industry standards.

#ProactiveInvestors #Botanix #ASX #Dermatology #ClinicalResearch #Commercialisation

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Elsight Ltd (ASX:ELS) CEO Yoav Amitai sits down with Proactive's Tylah Tully live from the ASX Small and Mid Cap Conference in September 2024.

Elsight was founded in 2009 by two ex-IDF soldiers from the Israeli intelligence community, and the company's first products were focused on audio and video transmission.

Following success in Israel's defence and homeland security sectors, Elsight joined the Australian Securities Exchange in 2017 (ASX:ELS). Since then, Elsight has launched its flagship 'Halo' product — the world’s premier beyond visual line of sight (BVLOS) connectivity solution for drones and other unmanned vehicles.

Today, Yoav says, Elsight has become the market leader in BVLOS communication solutions and has partnered with more than 70 different drone and UAV manufacturers and operators that are using Halo as their connectivity solution.

#ProactiveInvestors #Elsight #ASX #Halo #Drones #BVLOS

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

DroneShield Ltd (ASX:DRO) CEO Oleg Vornik chats with Proactive's Tylah Tully live from the ASX Small and Mid Cap Conference in September 2024.

DroneShield is an Australian publicly listed company with operations in Australia and the United States. The company provides counter-UAS protection, focusing on radio frequency sensing, artificial intelligence and machine learning, sensor fusion, electronic warfare, rapid prototyping and MIL-SPEC manufacturing.

DroneShield's capabilities are used to protect military, government, law enforcement, critical infrastructure, commercial and VIPs throughout the world. Vornik says the ASX-lister offers bespoke solutions and off-the-shelf products designed to suit a variety of terrestrial, maritime or airborne platforms.

#ProactiveInvestors #DroneShield #ASX #ElectronicWarfare #ThreatProtection #ArtificialIntelligence

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Downing Renewables & Infrastructure Trust PLC (LSE:DORE)manager Tom Williams talked with Proactive's Stephen Gunnion about the company's recent performance and strategic plans. He discussed the trust's diversified investments across hydropower, wind, and solar assets in Northern Europe and the UK, emphasising the importance of asset optimisation. Williams highlighted that since their IPO, the trust has achieved a 37-38% total return on NAV, making it the second-best performer in its peer group over the last year.

One of the key initiatives discussed was the improvement and value growth of the Gabrielsberget wind farm in Sweden, now valued 50% higher than its acquisition price two years ago. Williams also shared the ongoing efforts in their hydropower portfolio, where modernisation and digitalisation of assets continue to drive enhanced revenues. Additionally, the trust has repurchased 4.2 million shares, a strategy Tom Williams confirmed will continue to provide shareholder value.

Looking ahead, Downing Renewables plans to sell its wind farm asset and reinvest the proceeds into its hydropower operations. Williams expressed optimism about future returns from their modernization programs and further growth prospects.

Watch the full interview to learn more about Downing Renewables' strategies. Don't forget to like the video, subscribe to Proactive's YouTube channel, and enable notifications for future updates.

#DowningRenewables #RenewableEnergy #InfrastructureTrust #Hydropower #WindFarmSale #InvestmentStrategy #TomWilliams #ProactiveInvestors #ShareBuyback #SustainableInvesting #EnergySector #NorthernEuropeInvestments #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews